Oncology - BMT/SCT News & Articles

1 Multiple Myeloma: Myeloablative Therapy with Autologous Stem Cell Support versus Chemotherapy: A Meta-analysis Anticancer Research, May 18, 2012    Evidence Based Medicine    Clinical Article

2 Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up American Journal of Hematology, May 16, 2012

3 Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma American Journal of Hematology, May 16, 2012

4 Allogeneic hematopoietic cell transplantation in patients 60 to 70 years of age with de novo high-risk MDS or secondary AML Biology of Blood and Marrow Transplantation, May 16, 2012    Clinical Article

5 Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma Bone Marrow Transplantation, May 16, 2012

6 Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients Bone Marrow Transplantation, May 16, 2012
Exclusive Author Commentary

7 Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma European Journal of Haematology, May 14, 2012

8 Comparison of early quality of life outcomes in autologous and allogeneic transplant patients Bone Marrow Transplantation, May 14, 2012
Exclusive Author Commentary

9 Safety of Posaconazole and Sirolimus Co-administration in Allogeneic Hematopoietic Stem-Cell Transplantation Biology of Blood and Marrow Transplantation, May 11, 2012    Clinical Article

10 A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome Annals of Hematology, May 10, 2012    Clinical Article

11 POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience Annals of Hematology, May 10, 2012

12 Early Recovery of Immunity after Cord-Blood Transplantation in Children: Qualitative Features and Impact of Cytomegalovirus Infection Acta Haematologica, May 10, 2012

13 Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories Journal of Clinical Oncology, May 9, 2012

14 Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients Supportive Care in Cancer, May 9, 2012

15 Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis Bone Marrow Transplantation, May 9, 2012

16 Primary Spinal Natural Killer/T-Cell Lymphoma Successfully Treated With Concurrent Chemoradiotherapy and Autologous Stem Cell Transplantation Spine, May 9, 2012

17 Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma Transfusion, May 9, 2012    Clinical Article

18 Success of allogeneic marrow transplantation for children with severe aplastic anaemia British Journal of Haematology, May 8, 2012

19 Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients International Journal of Hematology, May 8, 2012    Clinical Article

20 Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation International Journal of Hematology, May 8, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia American Journal of Hematology, April 12, 2012

2 A multi-center, randomized, open label study comparing the efficacy and safety of micafungin vs. itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation, April 4, 2012

3 Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation International Journal of Hematology, April 5, 2012

4 Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients Leukemia, April 6, 2012

5 Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study Annals of Oncology, April 5, 2012

6 Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis Hematological Oncology, April 9, 2012    Evidence Based Medicine

7 Next generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma International Journal of Cancer, April 9, 2012

8 Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation Cancer, April 17, 2012

9 Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients Clinical Cancer Research, April 13, 2012

10 Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation Cancer, April 27, 2012

11 A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper Multiple Sclerosis, March 23, 2012

12 Melphalan 180mg/m² can be safely administered as Conditioning Regimen prior to an Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients with Creatinine Clearance 60ml/min/1.73 m² or lower with use of palifermin for Cytoprotection Biology of Blood and Marrow Transplantation, April 2, 2012

13 Bone Marrow B-cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development Biology of Blood and Marrow Transplantation, April 2, 2012

14 Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia Biology of Blood and Marrow Transplantation, April 2, 2012

15 Comparison of Outcomes after HLA-matched Sibling and Unrelated Donor Transplantation for Children with High-Risk Acute Lymphoblastic Leukemia Biology of Blood and Marrow Transplantation, April 2, 2012

16 Mobilized Peripheral Blood Stem Cells Compared with Bone Marrow as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced Intensity Conditioning in Patients with Acute Myeloid Leukemia in Complete Remission Biology of Blood and Marrow Transplantation, April 2, 2012

17 Dual-energy X-ray absorptiometry and biochemical markers of bone turnover after autologous stem cell transplantation in myeloma European Journal of Haematology, March 27, 2012

18 Allogeneic hematopoietic stem cell transplantation for adult over 40 years old with acquired aplastic anemia Biology of Blood and Marrow Transplantation, April 5, 2012

19 The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation Annals of Hematology, March 1, 2012

20 Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation Supportive Care in Cancer, April 20, 2012